A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director Product Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$197.1k - $266.7k

About the Job

Requirements

  • A degree in pharmaceutical sciences, chemistry, chemical engineering, or biochemical engineering is required.
  • A Ph.D. or M.S. degree and at least 16 years of experience in pharmaceutical process development are required.
  • Demonstrated experience in process development and process validation of sterile drug products and dosage forms across multiple development projects, including process transfer and management of cGMP contract manufacturing, is required.
  • Demonstrated management experience with successful drug product process development teams is required.
  • Experience collaborating closely with technical, regulatory, quality, clinical, project management, legal, finance, and supply chain functions in a cGMP operational environment is required.
  • Experience preparing regulatory documents, including briefing documents for regulatory meetings, INDs, and NDAs, is required.
  • In-depth understanding and hands-on experience in drug product formulation, process development, and characterization are required.
  • Hands-on experience with analytical methods for characterization of drug products and processes is required.
  • Strong leadership, organizational, communication, operational execution, and problem-solving skills are required.
  • If employed in the U.S., full vaccination against COVID-19 as defined by the Centers for Disease Control and Prevention is required.

Responsibilities

  • Lead drug product and process development, optimization, scale-up, characterization, and pre-validation.
  • Author and review technical protocols and reports supporting late-phase manufacture and process-characterization activities.
  • Lead preparation of the Drug Product section of regulatory filings and represent the Drug Product function in interactions with regulatory authorities.
  • Contribute to strategic technical discussions and present progress at internal and external scientific meetings.
  • Represent Drug Product development on cross-functional teams, including internal program teams and external contract manufacturing or corporate partners.
  • Integrate Drug Product activities with other CMC functions, including Drug Substance Development and Manufacturing, Analytical Development, Quality Assurance, and Regulatory Affairs.
  • Travel periodically to manufacturing and other partner sites.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs